Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : L-VALINE
Therapeutic Area : Genetic Disease
Study Phase : Undisclosed
Sponsor : Birmingham Women's and Children's NHS Foundation Trust
Deal Size : Inapplicable
Deal Type : Inapplicable
Liquid Valine and Isoleucine in Maple Syrup Urine Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 03, 2024
Lead Product(s) : L-VALINE
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Sponsor : Birmingham Women's and Children's NHS Foundation Trust
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-VALINE
Therapeutic Area : Nephrology
Study Phase : Phase I
Sponsor : National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 30, 2023
Lead Product(s) : L-VALINE
Therapeutic Area : Nephrology
Highest Development Status : Phase I
Sponsor : National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio
Deal Size : Inapplicable
Deal Type : Inapplicable